Charleston Oncology

Dr. Charles Greenberg practices medicine in the area of nonmalignant blood disorders. He provides consultative advice regarding the diagnosis and treatment of bleeding, thrombosis, and disorders of blood cells. Dr. Greenberg conducts translational research regarding new diagnostic tests for management of bleeding and thrombotic disorders. Working in collaborations within the MUSC health care system he assists in management of blood, blood products, and the cost-effective management on nonmalignant blood disorders. Clinical research on the use new approaches to manage bleeding and thrombosis continue as part of national and international groups targeting life-threatening blood disorders. Dr. Greenberg's basic research is in the area of transglutaminase structure and function and he has published in the area of Factor XIII and tissue transglutaminase biology related to hemostasis, thrombosis, wound healing, angiogenesis, and tumor growth.

Dr. Lockett is a Professor of Surgery in the Department of Surgery where he works in the Surgical Oncology Division. He serves as the MUSC Health's Chief Quality Officer for Charleston, where he leads MUSC Health – Charleston in continued efforts to provide the safest and highest quality care for patients by building a culture and systems that foster excellence. His academic interest lies in improving the quality, safety, and value of surgical care and addressing the surgical aspects of the opioid crisis. He is the principal investigator and surgeon lead for the South Carolina Surgical Quality Collaborative where he guides Continuous Quality Improvement work in eighteen hospitals across the state. He serves a similar role in the VA as the chief surgical consultant for Veterans Integrated Service Network 7 (Alabama, Georgia, and South Carolina) where he provides guidance to seven surgical programs in the region. He works with the Institute for Healthcare Improvement on surgical projects and served as a member of the VA's General Surgery Advisory Board. His primary areas of surgical expertise include the management of breast cancer and breast diseases. He has multiple peer-reviewed publications in both surgical oncology and general surgery. Dr. Lockett has a strong interest in surgical quality, safety, and value; surgical education, continuous quality improvement; system design, and pain management. He served as the surgical residency program director at East Tennessee State University before joining MUSC and the VA. He is the recipient of multiple teaching awards and has been an invited speaker at regional and national meetings. He is a member of MUSC's Surgical Leadership Council, Quality Committee, and Clinical Council. Within the VA, Dr. Lockett chairs or participates in multiple local, regional, and national committees including: the Academic Partnership Council, Quality Executive Committee, Patient Care Improvement Conference, Clinical Executive Board; National, VISN, and local surgical work groups; VISN Healthcare Delivery Council, Peer Review Committee, Invasive Procedures Committee, and the Strategic Analytics for Improvement and Learning national work group.

William G. Hawkins, M.D. is a surgical oncologist with 20 years of experience treating patients with some of the most challenging abdominal cancers. His clinical practice focuses on surgery for abdominal cancers, including pancreas cancer, liver cancer, gallbladder cancer, and sarcoma. Dr. Hawkins also cares for patients with complex benign abdominal cases, such as those in need of surgical intervention for bile duct injuries. With a longstanding commitment to leadership, patient care, education and research, Dr. Hawkins has spent 20 years at Washington University School of Medicine in St. Louis and its Siteman Cancer Center, where he obtained and directed a prestigious Specialized Program of Research Excellence (SPORE) grant to conduct multiple projects investigating pancreatic cancer. While there, he served as the chief of Hepatobiliary Pancreatic and Upper Gastrointestinal Surgery. In his administrative leadership role, Dr. Hawkins is the deputy director of the Hollings Cancer Center, where he focuses on strengthening translational research, increasing clinical trials across South Carolina, and assisting Jason Newman, M.D., FACS, chief of the Oncology Integrated Center of Clinical Excellence, with making clinical operations more efficient. He also serves as the Vice Chair for Clinical Affairs in the MUSC Department of Surgery. Dr. Hawkins completed fellowships in surgical oncology and research at Memorial Sloan Kettering Cancer Center, New York, New York; served as chief during his surgical residency at Massachusetts General Hospital, Boston, Massachusetts; and received both his medical and bachelor's degrees at the State University of New York at Stony Brook.